DJIA 18,041.54 -190.48 -1.04%
NASDAQ 5,032.75 -56.61 -1.11%
S&P 500 2,104.20 -21.86 -1.03%
market minute promo

Gilead Sciences (NASDAQ: GILD)



company name or ticker
Company Photos
(Click to zoom)

Jim Cramer -- Stock Market's Takeover Frenzy Won't End Anytime Soon

3 Best Biotech Stocks to Add to Your Portfolio

Alnylam Files Clinical Trial Application for ALN-AAT - Analyst Blog

The Best Blue Chips to Own Forever

One Motley Fool offers up his top blue-chip stocks to own in long-term portfolios.

AbbVie's Humira Gets FDA Orphan Status for Skin Disease - Analyst Blog

AbbVie's Humira Gets FDA Orphan Status for Skin Disease - Analyst Blog

Why Achillion Pharmaceuticals, Inc. Shares Soared Today

Achillion Pharmaceuticals shares are heading higher on hopes that a suitor may emerge.

Learning From The Masters: Q&A Session With Rosenose

Illustrating Johnson & Johnson's Fair Value

This Experimental Drug Could Finally Cure HIV

Gilead Sciences is developing an experimental drug that could lead to a functional cure for HIV. Here's what you need to know right now.

3 Types of Risks Facing Biotech Stocks

Biotech stocks have been dramatically outperforming the broader market, but that doesn't mean they're free of risk. Here are three types of risks all biotech stocks face.
See More Articles...